BiotechTube
Home/Rio Pharmaceuticals/John Forsayeth, Ph.D.
JF

John Forsayeth, Ph.D.

Executive Chairman

Rio Pharmaceuticals

Therapeutic Areas

NeurologyOncology

Rio Pharmaceuticals Pipeline

DrugIndicationPhase
RP115Alzheimer's DiseaseClinical Trial

Leadership Team at Rio Pharmaceuticals

JG
John Gerdes, Ph.D.
President
View full Rio Pharmaceuticals profile